Evidence that 20-HETE contributes to the development of acute and delayed cerebral vasospasm

REFERENCES

• Broderick JP, Brott TG, Duldner JE, et al. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 1994; 25: 1342–1347
   PubMed Web of Science ®Google Scholar
• Hop JW, Rinkel GJ, Algra A, et al. Case-fatality rates and functional outcome after subarachnoid hemorrhage: A systematic review. Stroke 1997; 28: 660–664
   PubMed Web of Science ®Google Scholar
• Adams HP, Jr, Kassell NF, Torner JC, et al. Early management of aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 181; 54: 141-145
   Google Scholar
• Cook DA. Mechanisms of cerebral vasospasm in subarachnoid haemorrhage. Pharmacol Ther 1995; 66: 259–284
   PubMed Web of Science ®Google Scholar
• Crompton MR. Cerebral infarction following the rupture of cerebral berry aneurysms. Brain 1964; 87: 263–279
   Web of Science ®Google Scholar
• Stoltenburg-Didinger G, Schwarz K. Brain lesions secondary to subarachnoid hemorrhage due to ruptured aneurysms. In: Cervos-Navarro J, Ferszt R, eds. Stroke and Microcirculation, New York: Raven Press, 1987: pp. 471–480
   Google Scholar
• Sundt TM, Jr, Whisnant JP. Subarachnoid hemorrhage from intracranial aneurysms. Surgical management and natural history of the disease. N Engl I Med 1978; 299: 116–122
   PubMed Web of Science ®Google Scholar
• Weir B. The pathophysiology of cerebral vasospasm. Br I Neurosurg 1995; 9: 375–390
   PubMed Web of Science ®Google Scholar
• Kawamura S, Sayama I, Yasui N, et al. Sequential changes in cerebral blood flow and metabolism in patients with subarach-noid haemorrhage. Acta Neurochir (Wien) 1992; 114: 12–15
   PubMed Web of Science ®Google Scholar
• Meixensberger J. Xenon-113 CBF measurements in severe head injury and subarachnoid haemorrhage. Acta Neurochir Suppl (Wien) 1993; 59: 28–33
   PubMedGoogle Scholar
• Meyer CH, Lowe D, Meyer M, et al. Progressive change in cerebral blood flow during the first three weeks after subar-achnoid hemorrhage. Neurosurgery 1983; 12: 58–76
   PubMed Web of Science ®Google Scholar
• Tranquart F, Ades PE, Groussin P, et al. Postoperative assessment of cerebral blood flow in subarachnoid haemorrhage by means of 99mTc-HMPAO tomography. Eur J Nucl Med 1993; 20: 53–58
   PubMedGoogle Scholar
• Macdonald RL, Weir BK, Marton LS, et al. Role of adenosine 5'-triphosphate in vasospasm after subarachnoid hemorrhage: Human investigations. Neurosurgery 2001; 48: 854–862
   PubMed Web of Science ®Google Scholar
• Megyesi JF, Vollrath B, Cook DA, et al. In vivo animal models of cerebral vasospasm: A review. Neurosurgery 2000; 46: 448–460
   PubMed Web of Science ®Google Scholar
• Sobey CG, Faraci FM. Subarachnoid haemorrhage: What happens to the cerebral arteries? Clin Exp Pharmacol Physiol 1998; 25: 867–876
   PubMed Web of Science ®Google Scholar
• Bederson JB, Levy, AL, Ding WH, et al. Acute vasoconstriction after subarachnoid hemorrhage. Neurosurgery 1998; 42: 352–360
   PubMed Web of Science ®Google Scholar
• Mursch K, Bransi A, Vatter H, et al. Blood flow velocities in middle cerebral artery branches after subarachnoid hemorrhage. I Neuroimaging 2000; 10: 157–61
   PubMed Web of Science ®Google Scholar
• Bederson JB, Germano IM, Guarino L. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke 1995; 26: 1086–1091
   PubMed Web of Science ®Google Scholar
• Delgado TJ, Brismar J, Svendgaard NA. Subarachnoid haemor-rhage in the rat: Angiography and fluorescence microscopy of the major cerebral arteries. Stroke 1985; 16: 595–602
   PubMed Web of Science ®Google Scholar
• Brawley BW, Strandness DE, Jr, Kelly WA. The biphasic response of cerebral vasospasm in experimental subarachnoid hemor-rhage. I Neurosurg 1968; 28: 1–8
   PubMed Web of Science ®Google Scholar
• Weir B, Grace M, Hansen J, et al. Time course of vasospasm in man. I Neurosurg 1978; 48: 173–178
   PubMed Web of Science ®Google Scholar
• Dorsch NW. Cerebral arterial spasm—a clinical review. Br I Neurosurg 1995; 9: 403–412
   PubMed Web of Science ®Google Scholar
• Minhas PS, Menon DK, Smielewski P, et al. Positron emission tomographic cerebral perfusion disturbances and transcranial Doppler findings among patients with neurological deterioration after subarachnoid hemorrhage. Neurosurgery 2003; 52: 1017–1022
   PubMed Web of Science ®Google Scholar
• Ohkuma H, Suzuki S, Kudo K, et al. Cortical blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage: Three-dimensional N-isopropyl-p-R123)1Hodoamphetamine sin-gle photon emission CT findings. AJNR Am] Neuroradiol 2003; 24: 444–450
   PubMed Web of Science ®Google Scholar
• D'Avella D, Germano A, Santoro G, et al. Effect of experimental subarachnoid hemorrhage on CSF eicosanoids in the rat. I Neurotrauma 1990; 7: 121–129
   PubMedGoogle Scholar
• Macdonald RL, Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991; 22: 971–982
   PubMed Web of Science ®Google Scholar
• Pluta RM, Afshar JK, Boock RJ, et al. Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglo-bin, and methemoglobin after subarachnoid hemorrhage. I Neurosurg 1998; 88: 557–561
   PubMed Web of Science ®Google Scholar
• Wickman G, Lan C, Vollrath B. Functional roles of the rho/rho kinase pathway and protein kinase C in the regulation of cerebrovascular constriction mediated by hemoglobin: Relevance to subarachnoid hemorrhage and vasospasm. Circ Res 2003; 92: 809–816
   PubMed Web of Science ®Google Scholar
• Yin W, Tibbs R, Tang J, et al. Haemoglobin and ATP levels in CSF from a dog model of vasospasm. J Clin Neurosci 2002; 9: 425–428
   PubMed Web of Science ®Google Scholar
• Kuroki M, Kanamuru K, Suzuki H, et al. Effect of vasospasm on heme oxygenases in a rat model of subarachnoid hemorrhage. Stroke 1998; 29: 683–689
   PubMed Web of Science ®Google Scholar
• Suzuki H, Kanamaru K, Tsunoda H, et al. Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J Clin Invest 1999; 104: 59–66
   PubMed Web of Science ®Google Scholar
• Fukuda K, Panter SS, Sharp FR, et al. Induction of heme oxygenase-1 (H0-1) after traumatic brain injury in the rat. Neurosci Lett 1995; 199: 127–130
   PubMed Web of Science ®Google Scholar
• Hoffman SW, Moore S, Ellis EF. Isoprostane: Free radical-generated prostaglandins with constrictor effects on cerebral arterioles. Stroke 1997; 28: 844–849
   PubMed Web of Science ®Google Scholar
• Hoffman SW, Rzigalinski BA, Willoughby, et al. Astrocytes generate isoprostanes in response to trauma or oxygen radicals. J Neurotrauma 2000; 17: 415–420
   PubMed Web of Science ®Google Scholar
• Sakamoto M, Takaki E, Yamashita K, et al. Nonenzymatic derived lipid peroxide, 8-iso-PGF2 alpha participates in the pathogenesis of delayed cerebral vasospasm in a canine SAH model. Neurol Res 2002; 24: 301–306
   PubMed Web of Science ®Google Scholar
• Armstead WM. Endothelins and the role of endothelin antagonists in the management of posttraumatic vasospasm. Curr Pharm Des 2004; 10: 2185–2192
   PubMed Web of Science ®Google Scholar
• Juvela S. Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage. J.Neurosurg 2000; 92: 390–400
   PubMed Web of Science ®Google Scholar
• Seifert V, Loffler BM, Zimmermann M, et al. Endothel in concentrations in patients with aneurysmal subarachnoid hemor-rhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 1995; 82: 55–62
   PubMed Web of Science ®Google Scholar
• Pickard JD, Walker V, Brandt L, et al. Effect of intraventricular haemorrhage and rebleeding following subarachnoid haemor-rhage on CSF eicosanoids. Acta Neurochir (Wien) 1994; 129: 152–157
   PubMed Web of Science ®Google Scholar
• Hirashima Y, Endo S, Kato R, et al. Prevention of cerebrovasos-pasm following subarachnoid hemorrhage in rabbits by the platelet-activating factor antagonist, E5880. J Neurosurg 1996; 84: 826–830
   PubMed Web of Science ®Google Scholar
• Cambj-Sapunar L, Yu M, Maier KM, et al. Contribution of 5HT1b receptors and 20-HETE to the fall in cerebral blood flow following SAH. Stroke 2003; 34: 1269–1279
   PubMed Web of Science ®Google Scholar
• Saida A, Ito H, Shibuya T, et al. Time-course alterations of monoamine levels and cerebral blood flow in brain regions after subarachnoid hemorrhage in rats. Brain Res Bull 1997; 43: 69–80
   PubMed Web of Science ®Google Scholar
• Harder DR. Increased sensitivity of cat cerebral arteries to serotonin upon elevation of transmural pressure. Pflugers Arch 1988; 411: 698–700
   PubMed Web of Science ®Google Scholar
• Mendelow AD, McCalden TA, Hattingh J, et al. Cerebrovascular reactivity and metabolism after subarachnoid hemorrhage in baboons. Stroke 1981; 12: 58–65
   PubMed Web of Science ®Google Scholar
• Murray MA, Faraci FM, Heistad DD. Effect of protein kinase C inhibitors on endothelin and vasopressin induced constriction of the rat basilar artery. Am] Physiol 1992; 263: H1643—H1649
   Google Scholar
• Sobey CG, Quan L. Impaired cerebral vasodilator responses to NO and PDE inhibition after subarachnoid hemorrhage. Am J Physiol 1999; 277: H1718—H1724
   Google Scholar
• Gewirtz RJ, Dhil Ion HS, Goes SE, et al. Lactate and free fatty acids after subarachnoid hemorrhage. Brain Res 1999; 840: 84–91
   PubMed Web of Science ®Google Scholar
• Pilitsis JG, Coplin WM, O'Regan MH, et al. Free fatty acids in human cerebrospinal fluid following subarachnoid hemorrhage and the potential role in vasospasm: A preliminary observation. J Neurosurg 2002; 97: 272–279
   PubMed Web of Science ®Google Scholar
• Pilitsis JG, Copl in WM, O'Regan MH, et al. Measurement of free fatty acids in cerebrospinal fluid from patients with hemorrhagic and ischemic stroke. Brain Res 2003; 985: 198–201
   PubMed Web of Science ®Google Scholar
• Clozel M, Watanabe H. BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci 1993; 52: 825–834
   PubMed Web of Science ®Google Scholar
• Si Foley PL, Caner HH, Kassell NF, et al. Reversal of subarachnoid hemorrhage-induced vasoconstriction with an endothelin recep-tor antagonist. Neurosurgery 1994; 34: 108–113
   PubMed Web of Science ®Google Scholar
• Josko J, Hendryk S, Jedrzejowska-Szypula H, et al. Influence endothelin ETA receptor antagonist-BQ123-on changes of endothelin-1 level in plasma of rats with acute vasospasm following subarachnoid hemorrhage. J Physiol Pharmacol 1998; 49: 367–375
   PubMed Web of Science ®Google Scholar
• Lan C, Das D, Wloskowkz A, et al. Endothelin-1 modulates hemoglobin-mediated signaling in cerebrovascular smooth mus-cle via Rhoa/Rho kinase and protein kinase C. Am] Physiol Heart Circ Physiol 2004; 286: H165—H173
   Google Scholar
• Trandafir CC, Nishihashi T, Wang A, et al. Participation of vasopressin in the development of cerebral vasospasm in a rat model of subarachnoid haemorrhage. Clin Exp Pharmacol Physiol 2004; 31: 261–266
   PubMed Web of Science ®Google Scholar
• Kaminogo M, Yonekura M, Onizuka M, et al. Combination of serine protease inhibitor FUT-175 and thromboxane synthetase inhibitor OKY-046 decreases cerebral vasospasm in patients with subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 1998; 38: 704–708
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Tanabe M, Okamoto H, et al. Effects of thromboxane synthetase inhibitor (RS-5186) on experimentally-induced cere-bral vasospasm. Neurol Res 1999; 21: 513–516
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Zhou C, Nanda A, et al. Ras protein contributes to cerebral vasospasm in a canine double hemorrhage model. Stroke 2002; 35: 1750–1755
   Web of Science ®Google Scholar
• Obara K, Nishizawa S, Koide M, et al. Interactive role of protein kinase C-delta and rho-kinase in the development of cerebral vasospasm in a canine two hemorrhage model. J Vasc Res 2005; 42: 62–76
   Google Scholar
• Kusaka G, Kimua H, Kusaka I, et al. Contribution of Src tyrosine kinase to cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 2003; 99: 383–390
   PubMed Web of Science ®Google Scholar
• Nishizawa S, Yamamoto S, Uemura K. Interrelation between protein Kinase C and nitric oxide in the development of vasospasm after subarachnoid hemorrhage. Neurol Res 1996; 18: 89–95
   PubMed Web of Science ®Google Scholar
• Laher I, Zhang JH. Protein kinase C and cerebral vasospasm. J Cereb Blood Flow Metab 2001; 21: 887–906
   PubMed Web of Science ®Google Scholar
• Matsui T, Sugawa M, Johshita H, et al. Activation of the protein kinase C-mediated contractile system in canine basilar artery undergoing chronic vasospasm. Stroke 1991; 22: 1183–1187
   PubMed Web of Science ®Google Scholar
• Sasaki T, Kasuya H, Onda H, et al. Role of p38 mitogen-activated protein kinase on cerebral vasospasm after subarachnoid hemorrhage. Stroke 2004; 35: 1466–1470
   PubMed Web of Science ®Google Scholar
• Miyagi Y, Carpenter RC, Meguro T, et al. Upregulation of rho A and rho kinase messenger RNAs in the basilar artery of a rat model of subarachnoid hemorrhage.] Neurosurg 2000; 93: 471–476
   PubMed Web of Science ®Google Scholar
• Harder DR, Dernbach P, Waters A. Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemor-rhage in the dog. J Clin Invest 1987; 80: 875–88
   PubMed Web of Science ®Google Scholar
• Kim P, Schini VB, Sundt TM, et al. Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res 1992; 70: 248–256
   PubMed Web of Science ®Google Scholar
• Sobey CG, Heistad DD, Faraci FM. Effect of subarachnoid hemorrhage on dilatation of rat basilar artery in vivo. Am] Physiol Heart Circ Physiol 1996; 271: H126—H132
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Nishizawa S, Yokoyama T, et al. Subarachnoid hemorrhage impairs cerebral blood flow response to nitric oxide but not to cyclic GMP in large cerebral arteries. Brain Res 1997; 757: 1–9
   PubMed Web of Science ®Google Scholar
• Schwartz AY, Sehba FA, Bederson JB. Decreased nitric oxide availability contributes to acute cerebral ischemia after subar-achnoid hemorrhage. Neurosurgery 2000; 47: 208–214
   PubMed Web of Science ®Google Scholar
• Harder DR, Gebremedhin D, Narayanan J, et al. Formation and action of a P-4504A metabolite of arachidonic acid in cat cerebral microvessels. Am] Physiol 1994; 266: H2098—H2107
   PubMed Web of Science ®Google Scholar
• Ito 0, Roman RJ. Regulation of P-4504A activity in the glomerul us of the rat. Am] Physiol 1999; 276: R1749—R1757
   PubMed Web of Science ®Google Scholar
• Zeldin DC, Plitman JD, Kobayashi J, et al. The rabbit pulmonary cytochrome P450 arachidonic acid metabolic pathway: Characterization and significance. J Clin Invest 1995; 95: 2150–2160
   PubMed Web of Science ®Google Scholar
• Node K, Huo Y, Ruan X, et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 1999; 285: 1276–1279
   PubMed Web of Science ®Google Scholar
• Muthal if MM, Benter IF, Karzoun N, et al. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci USA 1998; 95: 12701–12706
   PubMed Web of Science ®Google Scholar
• Powell PK, Wolf I, Jin R, et al. Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: Involvement of CYP4F2 and CYP4A11. J Pharmacol Exp Ther 1998; 285: 1327–1336
   PubMed Web of Science ®Google Scholar
• Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002; 82: 131–185
   PubMed Web of Science ®Google Scholar
• Hardwick JP, Song BJ, Huberman E, et al. Isolation, complemen-tary DNA sequence, and regulation of rat hepatic lauric acid co-hydroxylase (cytochrome P-450LAw). Identification of a new cytochrome P-450 gene family. J Biol Chem 1987; 262: 801–810
   PubMed Web of Science ®Google Scholar
• Helvig C, Dishman E, Capdevila JH. Molecular, enzymatic and regulatory characterization of rat kidney cytochromes P4504A2 and 4A3. Biochemistry 1998; 37: 12546–12558
   PubMed Web of Science ®Google Scholar
• Simpson AE. The cytochrome P4504 (CYP4) family. Gen Pharmacol 1997; 28: 351–359
   PubMedGoogle Scholar
• Kawashima H, Kusunose E, Thompson CM, et al. Protein expression, characterization, and regulation of CYP4F4 and CYP4F5 cloned from rat brain. Arch Biochem Biophys 1997; 347: 148–154
   PubMed Web of Science ®Google Scholar
• Bylund .1, Harder AG, Maier KG, et al. Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6. Arch Biochem Biophys 2003; 78: 34–41
   Google Scholar
• Xu F, Falck JR, Ortiz de Montellano PR, et al. Catalytic activity and isoform specific inhibition of rat cytochrome p4504F enzymes. I Pharmacol Exp Ther 2004; 308: 887–895
   Google Scholar
• Imaoka S, Shimojo N, Fimae Y. Induction of renal cytochrome P-450 in hepatic microsomes of diabetic rats. Biochem Biophys Res Commun 1988; 152: 680–687
   PubMed Web of Science ®Google Scholar
• Barnett CR, Gibson GG, Wolf CR, et al. Induction of cytochrome P45011I and P450IV family proteins in streptozotocin-induced diabetes. Biochem 11990; 268: 765-769
   Google Scholar
• Catella F, Lawson JA, Fitgzerald DJ, et al. Endogenous biosynth-esis of arachidonic acid epoxides in humans: Increased formation in pregnancy-induced hypertension. Proc Natl Acad Sci USA 1999; 87: 5893–5897
   Google Scholar
• Muerhoff AS, Williams DE, Leithauser MT, et al. Regulation of the induction of a cytochrome P-450 prostaglandin omega-hydroxylase by pregnancy in rabbit lung. Proc Natl Acad Sci USA 1987; 84: 7911–7914
   PubMed Web of Science ®Google Scholar
• Sacerdoti D, Balazy M, Angeli P, et al. Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE. I Clin Invest 1997; 100: 1264–1270
   PubMed Web of Science ®Google Scholar
• Escalante B, Sacerdoti D, Davidian MM, et al. Chronic treatment with tin normalizes blood pressure in spontaneously hypertensive rats. Hypertension 1991; 17: 776–779
   PubMed Web of Science ®Google Scholar
• Stec DE, Trolliet MR, Krieger JE, et al. Renal cytochrome P4504A activity and salt sensitivity in spontaneously hypertensive rats. Hypertension 1996; 27: 1329–1336
   PubMed Web of Science ®Google Scholar
• Sundseth SS, Alberta JA, Waxman DJ. Sex-specific, growth hormone-regulated transcription of the cytochrome P4502C11 and 2C12 genes. I Biol Chem 1992; 267: 3907–3914
   Web of Science ®Google Scholar
• Sewer MB, Koop DP, Morgan ET. Endotoxemia in rats is associated with induction of the P4504A subfamily and suppres-sion of several other forms of cytochrome P450. Drug Metab Dispos 1996; 24: 401–407
   PubMed Web of Science ®Google Scholar
• Khatsenko 0, Kikkawa Y. Nitric oxide differentially affects constitutive cytochrome P450 isoforms in rat liver. I Pharmacol Exp Ther 1997; 280: 1463-1470
   Google Scholar
• Collins XH, Harmon SD, Kaduce TL, et al. Omega-oxidation of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral micro-vascular smooth muscle and endothelium by alcohol dehydro-genase 4. J Biol Chem 2005; 280: 33157–33164
   PubMed Web of Science ®Google Scholar
• Escalante B, Sessa WC, Falck JR, et al. Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase. I Pharmacol Exp Ther 1989; 248: 229–232
   PubMed Web of Science ®Google Scholar
• Hoagland KM, Maier KG, Roman RJ. Contributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats. Hypertension 2003; 41: 697–702
   PubMed Web of Science ®Google Scholar
• Lange A, Gebremedhin D, Narayanan J, et al. 20-hydroxyeico-satetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C. I Biol Chem 1997; 272: 27345–27352
   Google Scholar
• Obara K, Koide M, Nakayama K. 20-hydroxyeicosatetraenoic acid potentiates stretch-induced contraction of canine basilarartery via PKC alpha-mediated inhibition of KCa channel. Br] Pharmacol 2002; 137: 1362–1370
   PubMed Web of Science ®Google Scholar
• Sun CW, Falck JR, Harder DR, et al. Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles. Hypertension 1999; 33: 414–418
   PubMed Web of Science ®Google Scholar
• Muthalif MM, Benter IF, Khandekar Z, et al. Contribution of Ras GTPase/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt-induced hypertension. Hypertension 2000; 35: 457–463
   PubMed Web of Science ®Google Scholar
• Muthalif MM, Karzoun NA, Gaber L, et al. Angiotensin II-induced hypertension: Contribution of Ras GTPase/Mitogen-activated protein kinase and cytochrome P450 metabolites. Hypertension 2000; 36: 604–609
   PubMed Web of Science ®Google Scholar
• Muthalif MM, Uddin MR, Fatima S, et al. Small GTP binding protein RAS contributes to norepinephrine-induced mitogenesis of vascular smooth muscle cells. Prostaglandins 2001; 65: 33–43
   PubMed Web of Science ®Google Scholar
• Randriamboavonjy V, Busse R, Fleming I. 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase. Hypertension 2003; 41: 801–806
   PubMed Web of Science ®Google Scholar
• Ma YH, Gebremedhin D, Schwartzman ML, et al. 20-hydro-xyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 1993; 72: 126–136
   PubMed Web of Science ®Google Scholar
• Sun CW, Alonso-Galicia M, Taheri MR, et al. Nitric oxide-20-hydroxyeicosatetraenoic acid interaction in the regulation of lc' channel activity and vascular tone in renal arterioles. Circ Res 1988; 83: 1069–1079
   Google Scholar
• Gebremedhin D, Lange AR, Narayanan J, et al. Cat cerebral arterial smooth muscle cells express cytochrome P4504A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current. Physiol 1998; 507: 771–781
   Web of Science ®Google Scholar
• Yu M, Cambj-Sapunar L, Kehl F, et al. Effects of a 20-HETE antagonist and agonists on cerebral vascular tone. Eur I Pharmacol 2004; 486: 297–304
   PubMed Web of Science ®Google Scholar
• Alonso-Galicia M, Maier KG, Greene AS, et al. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. Am] Physiol Regul Integr Comp Physiol 2002; 283: R60—R68
   PubMed Web of Science ®Google Scholar
• Oyekan A, Balazy M, McGiff JC. Renal oxygenases: Differential contribution to vasoconstriction induced by ET-1 and ANG II. Am I Physiol 1997; 273: R293—R300
   PubMed Web of Science ®Google Scholar
• Oyekan AO, McAward K, Conetta J, et al. Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension. Am J Physiol 1999; 276: R766—R775
   PubMed Web of Science ®Google Scholar
• Vazquez B, Rios A, Escalante B. Arachidonic acid metabolism modulates vasopressin-induced renal vasoconstriction. Life Sci 1995; 56: 1455–1466
   PubMed Web of Science ®Google Scholar
• Inscho EW, LeBlanc EA, Pham BT. Purinoceptor-mediated calcium signaling in preglomerular smooth muscle cells. Hypertension 1999; 33: 195–200
   PubMed Web of Science ®Google Scholar
• Kaide JI, Zhang FW, Jiang H, et al. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest 2000; 107: 1163–1171
   Web of Science ®Google Scholar
• Gebremedhin D, Lange AR, Lowry TF, et al. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res 2000; 87: 4–5
   PubMedGoogle Scholar
• Zou AP, Fleming JT, Falck JR, et al. 20-HETE is an endogenous inhibitor of the large-conductance Ca2+-activated IC' channel in renal arterioles. Am] Physiol 1996; 270: R228—R237
   PubMed Web of Science ®Google Scholar
• Kehl F, Cambj-Sapunar L, Maier KG, et al. 20-HETE contributes to the acute fall in cerebral blood after subarachnoid hemorrhage in the rat. Am J Physiol Heart Circ Physiol 2002; 282: H1556—H1565
   PubMed Web of Science ®Google Scholar
• Miyata N, Seki T, Tanaka Y, et al. Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-0111N-(3-chloro-4-morpholin-4-y1) phenyl-N'-hydroxyimido formamidel, on hemorrhagic and ischemic stroke. ] Pharmacol Exp Ther 2005; 314: 77-85
   Google Scholar
• Takeuchi K, Miyata N, Renic M, et al. Hemoglobin, NO and 20-HETE interactions in mediating cerebral vasoconstriction follow-ing SAH. Am] Physiol Regul Integr Comp Physiol 2006; 290: R84—R89
   PubMed Web of Science ®Google Scholar
• Hacein-Bey L, Harder DR, Varelas PN, et al. Improvement in angiographic vasospasm with a 20-HETE enzyme inhibitor in a subarachnoid hemorrhage dog model. Am I Neuroradiol 2006; 27: 1350–1354
   PubMed Web of Science ®Google Scholar
• Takeuchi K, Renic M, Bohman QC, et al. Reversal of delayed vasospasm by an inhibitor of the synthesis of 20-HETE. Am I Physiol Heart Circ Physiol 2005; 289: H2203—H2211
   PubMed Web of Science ®Google Scholar